4.7 Review

Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 34, 期 3, 页码 201-222

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2019.7994

关键词

glycomacropeptide; casein; oxidative stress; cardiometabolic disorders; inflammation; microbiota

资金

  1. CIHR Funding Source: Medline

向作者/读者索取更多资源

The review critically addresses the challenging issue of clinical utility of GMP in improving MetS outcomes, emphasizing its importance in alleviating obesity, OxS, inflammation, IR, dyslipidemia, and hypertension. The mechanisms of action will be analyzed and the various gaps of knowledge in this area will be specified. Valuable data from cellular, preclinical, and clinical investigations have highlighted the preventive and therapeutic actions of GMP towards MetS.
Significance:Metabolic syndrome (MetS) represents a cluster of cardiometabolic disorders, which accelerate the risk of developing diabetes, nonalcoholic fatty liver disease, and cardiovascular disorders such as atherosclerosis. Oxidative stress (OxS) and inflammation contribute to insulin resistance (IR) that greatly promotes the clinical manifestations of MetS components. Given the growing prevalence of this multifactorial condition, its alerting comorbidities, and the absence of specific drugs for treatment, there is an urgent need of prospecting for alternative nutraceutics as effective therapeutic agents for MetS. Recent Advances:There is a renewed interest in bioactive peptides derived from human and bovine milk proteins given their high potential in magnifying health benefits. Special attention has been paid to glycomacropeptide (GMP), a bioactive and soluble derivative from casein and milk whey, because of the wide range of its health-promoting functions perceived in the MetS and related complications. Critical Issues:In the present review, the challenging issue relative to clinical utility of GMP in improving MetS outcomes will be critically reported. Its importance in alleviating obesity, OxS, inflammation, IR, dyslipidemia, and hypertension will be underlined. The mechanisms of action will be analyzed, and the various gaps of knowledge in this area will be specified. Future Directions:Valuable data from cellular, preclinical, and clinical investigations have emphasized the preventive and therapeutic actions of GMP toward the MetS. However, additional efforts are needed to support its proofs of principle and causative relationship to translate its concept into the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据